Sign In
Buy LCID
$5.15
-0.0400 (-0.771%)
At Close: Jun 24, 2026
50% of the orders we have are from former Tesla orders, Lucid Interim CEO says
06:00pm, Friday, 28'th Mar 2025
Lucid Interim CEO Marc Winterhoff discusses the company's growth and goals on 'The Claman Countdown.'
Lucid to ramp customer deliveries for Gravity SUV by end of April
11:42am, Friday, 28'th Mar 2025
Lucid Motors plans to resume customer deliveries for its new all-electric Gravity SUV at the end of April. Getting the Gravity into customer hands is a big milestone for Lucid, whose success will hing
Campaign will coincide with Esophageal Cancer Awareness Month and will be featured at the upcoming Digestive Disease Week (DDW) Conference NEW YORK , March 27, 2025 /PRNewswire/ -- Lucid Diagnostics I
Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
08:01am, Monday, 24'th Mar 2025
Processed a record 4,042 EsoGuard tests in 4Q24, a 45% sequential and 84% annual increase Recognized EsoGuard revenue of $1.2 million in 4Q24 New sales channel generated over 20 new cash-pay concie
Think It's Too Late to Buy Lucid Group? Here's the Biggest Reason Why There's Still Time.
08:45am, Saturday, 22'nd Mar 2025
Typically, stocks expected to grow sales significantly in the year to come are priced at a premium. And to be sure, Lucid Group (LCID 5.92%) shares aren't necessarily cheap at 7.3 times sales.
Is Lucid Group Stock a Buy Now?
09:45am, Friday, 21'st Mar 2025
Lucid Group (LCID 1.75%) is a premium electric vehicle (EV) manufacturer that has captured attention with its innovative automotive offerings. The company has made noteworthy advancements in EV techno
Lucid's Stock Comeback—Is a Long-Term Recovery Ahead?
08:07am, Friday, 21'st Mar 2025
Lucid Group, Inc. NASDAQ: LCID, a luxury electric vehicle (EV) manufacturer, has seen dramatic stock price fluctuations in recent months. After a prolonged period of volatility and decline, Lucid's s
Lucid Doubling Production Isn't Enough: Why the EV Maker's Financial Forecast Signals Risks Through 2026
10:00am, Thursday, 20'th Mar 2025
Lucid Group (LCID -3.07%) is one of many electric vehicle (EV) start-ups trying to catch the lightning in a bottle that was Tesla. Given the increase in competition in the vehicle niche, investors hav
Lucid stock trading volume hits 5-month high; Buy signal or false alarm?
09:57am, Thursday, 20'th Mar 2025
Although its 2021 initial public offering (IPO) attracted plenty of attention, Lucid Motors has seen consistent struggles with profitability and production thus far.
Lucid Diagnostics Announces Updated National Comprehensive Cancer Network® (NCCN) Guidelines Now Include Esophageal Precancer Screening
08:31am, Thursday, 20'th Mar 2025
Highlights society guidelines recommending non-endoscopic biomarker testing, such as Lucid's EsoGuard Esophageal DNA Test, as an acceptable alternative to endoscopy NEW YORK , March 20, 2025 /PRNewswi
If You'd Invested $1,000 in Lucid Stock 4 Years Ago, Here's How Much You'd Have Today
08:00am, Wednesday, 19'th Mar 2025
Lucid Group (LCID 9.26%) debuted on the Nasdaq stock exchange with much fanfare on July 26, 2021 after merging with a special purpose acquisition company (SPAC). The electric-vehicle (EV) stock jumped
Market sell-off drags Dow, S&P 500 down; Tesla, Google dip and Lucid surges
01:40pm, Tuesday, 18'th Mar 2025
After two straight trading days of gains, US stocks fell on Tuesday as the sell-off resumed once again. At the time of writing, the Dow Jones Industrial Average was down 0.5%, while the S&P 500 inde
Why Lucid Motors Stock Soared Today
11:40am, Tuesday, 18'th Mar 2025
Lucid (LCID 12.96%) got an upgrade today, and the stock is soaring. However, overall, shares of the luxury electric vehicle (EV) maker aren't having a good start to the year.
Analyst updates Lucid stock price target on AI integration
10:56am, Tuesday, 18'th Mar 2025
Despite the hype from the initial public offering (IPO) era and the backing of one of the richest entities in the world, the Saudi Arabian Public Investment Fund (PIF), Lucid (NASDAQ: LCID), hasn't ex
Lucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication
08:31am, Tuesday, 18'th Mar 2025
Study confirms clinical utility of EsoGuard as a non-invasive triage tool to significantly increase positive yield of invasive upper endoscopy NEW YORK , March 18, 2025 /PRNewswire/ -- Lucid Diagnosti
